The effect of mGluR2 activation on signal transduction pathways and neuronal cell survival

Hyoung-gon Lee1, Xiongwei Zhu, Gemma Casadesus

  • 1Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA. Hyoung-gon.lee@case.edu

Brain Research
|November 26, 2008
PubMed

Insights

Metabotropic glutamate receptor 2 (mGluR2) activation promotes neuronal survival in Alzheimer disease (AD) models by activating pro-survival pathways and reducing oxidative stress. This suggests mGluR2 plays a neuroprotective role in AD pathogenesis.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Molecular Biology

Background:

  • Previous studies identified altered signal transduction pathways, including mitogen-activated protein kinase (MAPK), in Alzheimer disease (AD).
  • mGluR2 was found to be elevated in hippocampal pyramidal neurons in AD, co-localizing with neurofibrillary pathology, suggesting its potential role in selective neuronal degeneration.

Purpose of the Study:

  • To investigate the mechanistic relevance of mGluR2 in neuronal function and survival within the context of AD.
  • To explore the downstream signaling pathways activated by mGluR2 and its impact on cellular processes relevant to AD.

Main Methods:

  • Utilized cell culture models to study the effects of mGluR2 activation.
  • Examined the activation of extracellular signal-related kinase (ERK) pathways following mGluR2 stimulation.
  • Assessed tau phosphorylation levels and the impact of mGluR2 activation on oxidative stress-mediated cytotoxicity.

Main Results:

  • Activation of mGluR2 leads to the activation of the pro-survival ERK pathway.
  • This pro-survival signaling is also ectopically activated in AD, highlighting its in vivo significance.
  • mGluR2 activation increases tau phosphorylation and reduces oxidative stress-induced neuronal cell death.
  • Tau phosphorylation appears to be a neuroprotective antioxidant response.

Conclusions:

  • mGluR2 activation may mediate neuronal survival in AD by engaging pro-survival signaling pathways and mitigating oxidative stress.
  • Tau phosphorylation, induced by mGluR2 activation, could represent a neuroprotective mechanism against cellular insults in AD.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...